Why this small cap biotech has rocketed 2,511% in the last 5 months

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a phenomenal 2,585%.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today. Zoono has seen very strong share price growth since last September, and particularly since the outbreak of the coronavirus.

The Zoono share price was sitting at just $0.072 in September last year and has since shot all the way up to $1.88 at the time of writing – a phenomenal 2,511% increase.

Zoono is a global biotech company that is involved in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions. The company currently has a market capitalization of $307 million.

Following the coronavirus outbreak, Zoono commented that there has been a high interest in Zoono's technology given its proven efficacy against viruses and bacteria, and ability to prevent cross-contamination.

Recently, Zoono reported unaudited revenues for the quarter so far to 10 February 2020 of NZ$2.4 million, with on-line sales in Australia and New Zealand contributing strongly.

Announcement in response to coronavirus

On 30 January 2020, Zoono announced to the market its confidence of being well-positioned to be part of the solution to both coronavirus and other new virus threats. The company believes that its Zoono technology, particularly its longevity and killing methodology, delivers an ideal solution.

At this time, the company stated that Zoono's Z71 Microbe Shield Surface Sanitiser was successfully tested in 2014 against bovine coronavirus (a surrogate recognised by the World Health Organisation for other members of the coronaviridae family, including the MERS virus). Test results confirmed a 99.99% efficacy in five minutes.

Zoono's Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser products were recently sent to a German laboratory for testing against the latest Chinese strain of the coronavirus (2019-nCoV).

Operationally, once the impact of the new coronavirus emerged, Zoono made an immediate decision in early January to ramp up production of its key active ingredients and its Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser finished goods.

Recent agreement for Chinese childcare & hotel sectors

A week ago, on February 10, Zoono announced it had entered into an exclusive distribution agreement with Beijing Youmeng Technology and Development Limited for the childcare and hotel sectors in China.

At this time, Zoono had received an initial payment of NZD$775,000 from Beijing Youmeng Technology and Development Limited.

Zoono commented that this agreement in the childcare and hotel sectors in China is another step in Zoono's strategy to focus on specific sectors and on the appointment of reputable distributors with explicit expertise in these market segments.

Zoono also pointed out that it has sought to exercise greater control over the activities and performance of its distributors in its new distribution arrangements.

This agreement is the fourth distribution agreement entered into by the company for an industry sector in the Chinese market in the last six months.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

man with dog on his lap looking at his phone in his home.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »